SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/12/18 Idt Corp 10-Q 1/31/18 69:4.3M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 398K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 20K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 21K 12: R1 Document and Entity Information HTML 42K 13: R2 Consolidated Balance Sheets HTML 130K 14: R3 Consolidated Balance Sheets (Parenthetical) HTML 44K 15: R4 Consolidated Statements of Operations (Unaudited) HTML 86K 16: R5 Consolidated Statements of Comprehensive Income HTML 45K (Loss) (Unaudited) 17: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 114K 18: R7 Consolidated Statements of Cash Flows HTML 23K (Parenthetical) (Unaudited) 19: R8 Basis of Presentation HTML 26K 20: R9 IDT Financial Services Holding Limited Assets and HTML 50K Liabilities Held for Sale 21: R10 Spin-Off of Rafael Holdings, Inc. and Investment HTML 41K in Rafael Pharmaceuticals, Inc. 22: R11 Marketable Securities HTML 67K 23: R12 Fair Value Measurements HTML 59K 24: R13 Equity HTML 44K 25: R14 Earnings (Loss) Per Share HTML 45K 26: R15 Revolving Credit Facility HTML 24K 27: R16 Accumulated Other Comprehensive Loss HTML 32K 28: R17 Business Segment Information HTML 46K 29: R18 Commitments and Contingencies HTML 53K 30: R19 Other Income (Expense), Net HTML 32K 31: R20 Income Tax and New Jersey Corporation Business Tax HTML 39K 32: R21 Recently Issued Accounting Standard Not Yet HTML 40K Adopted 33: R22 IDT Financial Services Holding Limited Assets and HTML 46K Liabilities Held for Sale (Tables) 34: R23 Proposed Spin-Off of Rafael Holdings, Inc. and HTML 26K Investment in Rafael Pharmaceuticals, Inc. (Tables) 35: R24 Marketable Securities (Tables) HTML 66K 36: R25 Fair Value Measurements (Tables) HTML 48K 37: R26 Equity (Tables) HTML 31K 38: R27 Earnings (Loss) Per Share (Tables) HTML 43K 39: R28 Accumulated Other Comprehensive Loss (Tables) HTML 30K 40: R29 Business Segment Information (Tables) HTML 39K 41: R30 Other Income (Expense), Net (Tables) HTML 30K 42: R31 IDT Financial Services Holding Limited Assets and HTML 91K Liabilities Held for Sale (Details) 43: R32 IDT Financial Services Holding Limited Assets and HTML 29K Liabilities Held for Sale (Details 1) 44: R33 IDT Financial Services Holding Limited Assets and HTML 30K Liabilities Held for Sale (Details Textual) 45: R34 Spin-Off of Rafael Holdings, Inc. and Investment HTML 29K in Rafael Pharmaceuticals, Inc. (Details) 46: R35 Spin-Off of Rafael Holdings, Inc. and Investment HTML 87K in Rafael Pharmaceuticals, Inc. (Details Textual) 47: R36 Marketable Securities (Details) HTML 69K 48: R37 Marketable Securities (Details 1) HTML 35K 49: R38 Marketable Securities (Details 2) HTML 44K 50: R39 Marketable Securities (Details 3) HTML 30K 51: R40 Marketable Securities (Details Textual) HTML 39K 52: R41 Fair Value Measurements (Details) HTML 38K 53: R42 Fair Value Measurements (Details 1) HTML 28K 54: R43 Fair Value Measurements (Details Textual) HTML 23K 55: R44 Equity (Details) HTML 62K 56: R45 Equity (Details Textual) HTML 64K 57: R46 Earnings (Loss) Per Share (Details) HTML 33K 58: R47 Earnings (Loss) Per Share (Details 1) HTML 28K 59: R48 Revolving Credit Facility (Details) HTML 41K 60: R49 Accumulated Other Comprehensive Loss (Details) HTML 49K 61: R50 Accumulated Other Comprehensive Loss (Details HTML 29K Textual) 62: R51 Business Segment Information (Details) HTML 45K 63: R52 Business Segment Information (Details Textual) HTML 21K 64: R53 Commitments and Contingencies (Details) HTML 48K 65: R54 Other Income (Expense), Net (Details) HTML 35K 66: R55 Income Tax and New Jersey Corporation Business Tax HTML 47K (Details) 68: XML IDEA XML File -- Filing Summary XML 123K 67: EXCEL IDEA Workbook of Financial Reports XLSX 71K 6: EX-101.INS XBRL Instance -- idt-20180131 XML 1.17M 8: EX-101.CAL XBRL Calculations -- idt-20180131_cal XML 144K 9: EX-101.DEF XBRL Definitions -- idt-20180131_def XML 523K 10: EX-101.LAB XBRL Labels -- idt-20180131_lab XML 1.10M 11: EX-101.PRE XBRL Presentations -- idt-20180131_pre XML 739K 7: EX-101.SCH XBRL Schema -- idt-20180131 XSD 145K 69: ZIP XBRL Zipped Folder -- 0001213900-18-002826-xbrl Zip 122K
EXHIBIT 31.2
CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Marcelo Fischer, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of IDT Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: March 12, 2018
/s/ Marcelo Fischer | |
Marcelo Fischer Senior Vice President of Finance (Principal Financial Officer) |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/12/18 | SC 13G/A | ||
For Period end: | 1/31/18 | |||
List all Filings |